Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 949.05
-20.75 (-2.14%)
Aug 1, 2025, 3:30 PM IST
Intra-Cellular Therapies Market Cap
Zydus Lifesciences has a market cap or net worth of 954.97 billion as of August 1, 2025. Its market cap has decreased by -19.90% in one year.
Market Cap
954.97B
Enterprise Value
954.83B
Revenue
232.42B
Ranking
n/a
PE Ratio
21.10
Stock Price
$949.05
Market Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 954.97B, an increase of 11,551.92%. That is a compound annual growth rate of 22.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 954.97B | -2.33% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | 488.07B | 87.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,910.20B |
| Divi's Laboratories | 1,688.78B |
| Cipla | 1,213.89B |
| Apollo Hospitals Enterprise | 1,078.10B |
| Mankind Pharma | 1,059.56B |
| Fortis Healthcare | 648.70B |
| Aurobindo Pharma | 627.15B |
| Alkem Laboratories | 585.75B |